{"id":"https://openalex.org/W2991606206","doi":null,"title":"Improving Diabetic Retinopathy Outcomes: FIELD Fenofibrate.","display_name":"Improving Diabetic Retinopathy Outcomes: FIELD Fenofibrate.","publication_year":2018,"publication_date":"2018-12-01","ids":{"openalex":"https://openalex.org/W2991606206","mag":"2991606206","pmid":"https://pubmed.ncbi.nlm.nih.gov/31313550"},"language":"en","primary_location":{"id":"pmid:31313550","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31313550","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of the Association of Physicians of India","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069847897","display_name":"Sanjay Kalra","orcid":"https://orcid.org/0000-0003-1308-121X","observed_orcids":["https://orcid.org/0000-0003-1308-121X"]},"institutions":[{"id":"https://openalex.org/I4210153282","display_name":"Bharti Hospital","ror":"https://ror.org/04vpecq51","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210153282"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sanjay Kalra","raw_affiliation_strings":["Consultant, Endocrinology, Bharti Hospital, Karnal, Haryana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consultant, Endocrinology, Bharti Hospital, Karnal, Haryana","institution_ids":["https://openalex.org/I4210153282"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041017184","display_name":"Rakesh Kumar Sahay","orcid":"https://orcid.org/0000-0002-5471-0695","observed_orcids":["https://orcid.org/0000-0002-5471-0695"]},"institutions":[{"id":"https://openalex.org/I99557698","display_name":"Osmania Medical College","ror":"https://ror.org/00hr54p22","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I99557698"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rakesh Sahay","raw_affiliation_strings":["Professor and HOD, Endocrinology, Osmania medical College,Hyderabad, Telangana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professor and HOD, Endocrinology, Osmania medical College,Hyderabad, Telangana","institution_ids":["https://openalex.org/I99557698"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"66","issue":"12","first_page":"55","last_page":"57"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":0.9150000214576721},{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.972000002861023},{"id":"https://openalex.org/keywords/retinal-vessels","display_name":"retinal vasculature","score":0.800000011920929},{"id":"https://openalex.org/keywords/lipid-lowering","display_name":"lipid lowering","score":0.7350000143051147},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.9819999933242798},{"id":"https://openalex.org/keywords/field-trials","display_name":"field trials","score":0.9049999713897705},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9010000228881836},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/perindopril","display_name":"perindopril","score":0.878000020980835},{"id":"https://openalex.org/keywords/ramipril","display_name":"ramipril","score":0.9700000286102295},{"id":"https://openalex.org/keywords/blood-pressure-lowering-agents","display_name":"blood pressure lowering agents","score":0.7749999761581421},{"id":"https://openalex.org/keywords/glucose-lowering-agents","display_name":"glucose-lowering agents","score":0.7649999856948853}],"concepts":[{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.9588310718536377},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9572195410728455},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.7156276106834412},{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.6949728727340698},{"id":"https://openalex.org/C2777748223","wikidata":"https://www.wikidata.org/wiki/Q1078392","display_name":"Indapamide","level":3,"score":0.6402719616889954},{"id":"https://openalex.org/C2779200603","wikidata":"https://www.wikidata.org/wiki/Q277785","display_name":"Perindopril","level":3,"score":0.6018833518028259},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5286339521408081},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5050387978553772},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4441656470298767},{"id":"https://openalex.org/C2779888176","wikidata":"https://www.wikidata.org/wiki/Q412666","display_name":"Ramipril","level":3,"score":0.4361184537410736},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4220002293586731},{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.4219658374786377},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41381511092185974},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.3402774930000305},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3360752463340759},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.19796347618103027}],"mesh":[{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:31313550","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31313550","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of the Association of Physicians of India","raw_type":"Journal Article"},{"id":"mag:2991606206","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31313550","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W202493534","https://openalex.org/W1971213885","https://openalex.org/W1974926415","https://openalex.org/W1975018096","https://openalex.org/W1986744233","https://openalex.org/W2043196998","https://openalex.org/W2073908806","https://openalex.org/W2094229974","https://openalex.org/W2097225786","https://openalex.org/W2103393658","https://openalex.org/W2131446563","https://openalex.org/W2132317196","https://openalex.org/W2137489898","https://openalex.org/W2144125787","https://openalex.org/W2145187213","https://openalex.org/W2146264128","https://openalex.org/W2252692890","https://openalex.org/W2317033463","https://openalex.org/W2425644022"],"related_works":["https://openalex.org/W4412444281","https://openalex.org/W2886999071","https://openalex.org/W2095723000","https://openalex.org/W3142771685","https://openalex.org/W2164883496","https://openalex.org/W2187478359","https://openalex.org/W2003397510","https://openalex.org/W4231769457","https://openalex.org/W4386099174","https://openalex.org/W4400691407"],"abstract_inverted_index":{"This":[0],"brief":[1],"communication":[2],"describes":[3],"evidence":[4],"which":[5],"proves":[6],"the":[7,13,39,55],"beneficial":[8],"effects":[9],"of":[10,41,57,66],"fenofibrate":[11,42],"on":[12],"retinal":[14,58],"vasculature":[15],"in":[16,61],"type":[17],"2":[18],"diabetes,":[19],"acting":[20],"via":[21],"both":[22],"lipid":[23],"lowering":[24,27,70,73],"and":[25,34,71,82],"non-lipid":[26],"mechanisms.":[28],"It":[29],"discusses":[30],"data":[31,52],"from":[32],"FIELD":[33],"other":[35,67],"trials":[36,65],"to":[37],"support":[38],"use":[40],"as":[43,76],"a":[44],"secondary":[45],"preventive":[46],"therapy":[47],"for":[48],"diabetic":[49],"retinopathy.":[50],"These":[51],"contrast":[53],"with":[54],"lack":[56],"benefit":[59],"shown":[60],"major":[62],"cardiovascular":[63],"outcome":[64],"blood":[68],"pressure":[69],"glucose":[72],"agents":[74],"such":[75],"empagliflozin,":[77],"liraglutide,":[78],"perindopril":[79],"+":[80],"indapamide,":[81],"ramipril.":[83]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-12-05T00:00:00"}